These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8386242)
1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591. Tagari P; Becker A; Brideau C; Frenette R; Sadl V; Thomas E; Vickers P; Ford-Hutchinson A J Pharmacol Exp Ther; 1993 Apr; 265(1):416-25. PubMed ID: 8386242 [TBL] [Abstract][Full Text] [Related]
2. Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen. Tagari P; Rasmussen JB; Delorme D; Girard Y; Eriksson LO; Charleson S; Ford-Hutchinson AW Eicosanoids; 1990; 3(2):75-80. PubMed ID: 2169776 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog. Pfeifer CA; Bottoms GD; Johnson MA; Fessler J Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594 [TBL] [Abstract][Full Text] [Related]
4. The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat. Foster A; Letts G; Charleson S; Fitzsimmons B; Blacklock B; Rokach J J Immunol; 1988 Nov; 141(10):3544-50. PubMed ID: 2846689 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors. Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271 [TBL] [Abstract][Full Text] [Related]
6. Antiasthmatic effects of a leukotriene biosynthesis inhibitor (MK-0591) in allergic dogs. Becker AB; Black C; Lilley MK; Bajwa K; Ford-Hutchinson AW; Simons FE; Tagari P J Appl Physiol (1985); 1995 Feb; 78(2):615-22. PubMed ID: 7759431 [TBL] [Abstract][Full Text] [Related]
7. Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs. Stevens WH; Lane CG; Woolley MJ; Ellis R; Tagari P; Black C; Ford-Hutchinson A; O'Byrne PM J Appl Physiol (1985); 1994 Apr; 76(4):1583-8. PubMed ID: 8045835 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of leukotriene C4, D4 and E4 in allergic inflammation in rats. Ohuchi K; Takahashi C; Watanabe M; Hirasawa N; Suzuki Y; Kudo M; Konishi T; Tsurufuji S J Clin Lab Immunol; 1988 Dec; 27(4):171-8. PubMed ID: 2855079 [TBL] [Abstract][Full Text] [Related]
9. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat. Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116 [TBL] [Abstract][Full Text] [Related]
10. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Westcott JY; Smith HR; Wenzel SE; Larsen GL; Thomas RB; Felsien D; Voelkel NF Am Rev Respir Dis; 1991 Jun; 143(6):1322-8. PubMed ID: 1646581 [TBL] [Abstract][Full Text] [Related]
11. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Bernard GR; Korley V; Chee P; Swindell B; Ford-Hutchinson AW; Tagari P Am Rev Respir Dis; 1991 Aug; 144(2):263-7. PubMed ID: 1650152 [TBL] [Abstract][Full Text] [Related]
12. Increased leukotriene E4 excretion during antigen-induced bronchoconstriction in allergic sheep. Tagari P; Abraham WM; McGolrick J; Charleson S; Soler M; Ahmed A; Cortez A; Ford-Hutchinson AW J Appl Physiol (1985); 1990 Apr; 68(4):1321-7. PubMed ID: 2161409 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of leukotriene C4 in the airways and subsequent urinary leukotriene E4 excretion in normal and asthmatic subjects. Westcott JY; Voelkel NF; Jones K; Wenzel SE Am Rev Respir Dis; 1993 Nov; 148(5):1244-51. PubMed ID: 7694531 [TBL] [Abstract][Full Text] [Related]
14. Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus. Hackshaw KV; Voelkel NF; Thomas RB; Westcott JY J Rheumatol; 1992 Feb; 19(2):252-8. PubMed ID: 1321246 [TBL] [Abstract][Full Text] [Related]
15. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. Hillingsø J; Kjeldsen J; Laursen LS; Lauritsen K; von Spreckelsen S; Depré M; Friedman BS; Malmström K; Shingo S; Bukhave K Clin Pharmacol Ther; 1995 Mar; 57(3):335-41. PubMed ID: 7697951 [TBL] [Abstract][Full Text] [Related]
16. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. Maclouf J; Antoine C; De Caterina R; Sicari R; Murphy RC; Patrignani P; Loizzo S; Patrono C Am J Physiol; 1992 Jul; 263(1 Pt 2):H244-9. PubMed ID: 1322060 [TBL] [Abstract][Full Text] [Related]
17. Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects. Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH Eur Respir J; 1994 May; 7(5):907-13. PubMed ID: 8050548 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the production and action of leukotrienes by MK-571 and MK-886. Ford-Hutchinson AW Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788 [No Abstract] [Full Text] [Related]
19. Metabolism of cysteinyl leukotrienes in monkey and man. Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780 [TBL] [Abstract][Full Text] [Related]